Comparative efficacy and risks of low molecular weight heparins and thrombolysis in massive pulmonary embolism without cardiogenic shock;Efficacite et risques compares des heparines de bas poids moleculaire et de la thrombolyse dans l'embolie pulmonaire massive sans etat de choc: A propos de 62 patients

Archives des Maladies du Coeur et des Vaisseaux

Volumn 91, Issue 3, 1998, Pages 295-299

  Hamel, E ^a   Pacouret, G ^a   Casset Senon, D ^b   Dessenne, X ^a   Bertrand, P ^c   Portier, J M ^b   Charbonnier, B ^a  

^a Unite de Soins Cardiaques Intensis   (France)

^b SERVICE DE DERMATOLOGIE   (France)

^c UNIVERSITÉ DE TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ANTIVITAMIN K; DALTEPARIN; ENOXAPARIN; FIBRINOLYTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; SARUPLASE; UROKINASE; WARFARIN;

ADULT; AGED; ARTICLE; BLEEDING; CARDIOGENIC SHOCK; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG EMBOLISM; LUNG SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; RECURRENT DISEASE; REPERFUSION; RISK BENEFIT ANALYSIS; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; COMPARATIVE STUDY; MIDDLE AGED; RETROSPECTIVE STUDY; RISK; SCINTISCANNING;

AGED; AGED, 80 AND OVER; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK; THROMBOLYTIC THERAPY;

EID: 0032015137     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Dolen JE. Clinical diagnosis of acute pulmonary embolism. In : Morpuggo M (ed). Pulmonary embolism. New York : Marcel Dekker Inc., 1994 : 55-66.
2. Alpert JS, Smith R, Carlson J Ockene IS, Dexter L, Dalen JE. Mortality in patients treated For pulmonary embolism. JAMA 1976 ; 236 : 1477-80.
3. UPET : The Urokinase Pulmonary Embolism Trial. A national cooperative study. Circulation 1973 ; 47 (suppl II) : II I-II 108.
4. Leizorovicz A, Simonneau G, Decousus H, Boissel JP. Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis : a meta-analysis. Br Med J 1994 ; 309 : 299-304.
5. Lensing AWA, Prins MH, Davidson BL, Hirsh J. Treatment of deep venous thrombosis with low molecular weight heparins : a meta-analysis. Arch Intern Med 1995 ; 155 : 601-7.
6. Hirsh J, Siragusa S, Cosmi B, Ginsberg JS. Low molecular weight heparins (LMWH) in the treatment of patients with acute venous thromboembolism. Thromb Haemost 1995 ; 74 : 360-3.
7. Miller GAH, Sutton GC, Kerr IH, Gibson RV, Honey M. Com parison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism. Br Med J 1971 ; 2 : 681-4.
8. Brochier M, Raynaud P, Fauchier JP et al. Comparison between lung scans and pulmonary angiograms in the evaluation of the perfusion defect in massive and submassive pulmonary embolism. Prog Respir Res 1980 ; 13 : 120-6.
9. Dean AG, Dean JA, Burton AH, Dicker RC. Epi Info, version 5 : a word processing, database, and statistics program for epidemiology on microcomputers. Centers for disease control. Atlanta, USA, 1990.
10. Sasahara AA. Fibrinolytic controversy Rebuttal. J Cardiovasc Med 1980 ; 4 : 813-4.
11. Konstantinides S, Kasper W, Kienast J et al. Favorable effect of thrombolytic treatment on the clinical outcome of hemodynamically stable patients with acute massive pulmonary embolism : The management and prognosis of pulmonary embolism registry (abstract). Circulation 1996 ; 94, 8 (suppl I) : 1 572.
12. Goldhaber SZ, Heit J, Sharma GVRK et al. Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism. Lancet 1988 ; 2 : 293-8.
13. Meyer G, Sors H, Charbonnier B et al. Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism : an European multicenter double-blind trial. J Am Coll Cardiol 1992 ; 19 : 239-45.
14. Sors H, Pacouret G, Azarian R, Meyer G, Charbonnier B, Simonneau G. Hemodynamic effects of bolus vs 2-h infusion or alteplase in acute massive pulmonary embolism : a randomized controlled multicenter trial. Chest 1994 ; 106 : 712-7.
15. Goldhaber SZ, Agnelli G, Levine MN. Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis : an international multicenter randomized trial. Chest 1994 ; 106: 718-24.
16. Charbonnier B, Pacouret G, Augusseau-Richard MP. Place de la thrombolyse dans le traitement des embolies pulmonaires. STV 1996 ; 8 : 17-26.
17. Pacouret G, Augusseau-Richard MP, Dessenne X, Pagot O, Charbonnier B. Embolie pulmonaire : quel thrombolytique choisir ? Arch Mal Cœur 1995 ; 88 : 1763-7.
18. Huet Y, Gouoult-Heilmann M, Contant G, Brun-Buisson C. Treatment of acute pulmonary embolism by a low molecular weight heparin fraction. A preliminary study. Intensive Care Med 1987 ; 13 : 126-30.
19. Quilliet L, Charbonnier B, Delahousse B et al. Traitement des embolies pulmonaires aiguës par une héparine de bas poids moléculaire par voie intraveineuse : recherche de la posologie optimale. Arch Mol Cœur 1988 ; 81 : 1219-25.
20. Théry C, Simonneau G, Meyer G et al. Randomized trial of subcutaneous low molecular weight heparin CY 216 (fraxiparine) compared with intravenous unfractionated heparin in the curative treatment of submassive pulmonary embolism ; a dose ranging study. Circulation 1992 ; 85 : 1300-9.
21. Hull RD, Pineo GF, Brant RF et al. Subcutaneous low molecular weight heparin compared with continuous intravenous heparin in the treatment of pulmonary embolism (abstract). Circulation 1994 ; 90 (IV, 2): 1569.
22. Meyer G, Brenot F, Pacouret G et al. Subcutaneous low molecular weight heparin Fragmin versus intravenous unfractionated heparin in the treatment of acute non massive pulmonary embolism : an open randomized pilot study. Thromb Haemost 1995 ; 74 : 1432-5.
23. Dalla-Volta S, Palla A, Santolicandro AM et al. PAIMS-2 : alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminoqen activator Italian multicenter study 2. J Am Coll Cardiol 1992 ; 20 : 520-6.
24. Goldhaber SZ, Haire WD, Feldstein ML et al. Alteplase versus heparin in acute pulmonary embolism : randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet 1993 ; 341 : 507-11.
25. Simonneau G, Sors H, Charbonnier B et al. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. N Engl J Med 1997 ; 337 : 663-9.